Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174383 | SCV000225674 | uncertain significance | not provided | 2014-10-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001078522 | SCV001006059 | benign | Oculofaciocardiodental syndrome | 2022-06-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336422 | SCV002638294 | likely benign | Inborn genetic diseases | 2019-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003927596 | SCV004746985 | likely benign | BCOR-related condition | 2019-09-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000174383 | SCV001799410 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174383 | SCV001970427 | uncertain significance | not provided | no assertion criteria provided | clinical testing |